{"name":"Takara Bio Inc.","slug":"takara-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"HF10 plus Ipilimumab","genericName":"HF10 plus Ipilimumab","slug":"hf10-plus-ipilimumab","indication":"Unresectable or metastatic melanoma","status":"phase_2"},{"name":"TBI-1301","genericName":"TBI-1301","slug":"tbi-1301","indication":"Relapsed or refractory multiple myeloma","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TBI-1501","genericName":"TBI-1501","slug":"tbi-1501","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"HF10 plus Ipilimumab","genericName":"HF10 plus Ipilimumab","slug":"hf10-plus-ipilimumab","phase":"phase_2","mechanism":"HF10 plus Ipilimumab is a combination of a heat shock protein 90 (HSP90) inhibitor and a CTLA-4 inhibitor, which works by blocking the activity of heat shock protein 90 and cytotoxic T-lymphocyte-associated protein 4, respectively, to enhance the immune response against cancer cells.","indications":["Unresectable or metastatic melanoma"],"catalyst":""},{"name":"TBI-1301","genericName":"TBI-1301","slug":"tbi-1301","phase":"phase_3","mechanism":"TBI-1301 is a monoclonal antibody targeting CD47.","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"TBI-1501","genericName":"TBI-1501","slug":"tbi-1501","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNUTJUUWVmYkRnLTdkMWJiSkRUSDRSZG1mR0tsTU5xd0V3NVR2aTM2U3JuQjhxRDZtSExpWGtmSzRJVGpaRHNJTFg5UU82cjhReXZSQUtPamJGellBRG5UZlBUTnJ5US1VTHpGUTVWUTNIcGFqZzlPSm9zRFlLallONFNTajVRc2NqLWo1Qy1oaXRUcHdQY3Z6NjhEU1MxdTN1V24zYmN2Ml93VDBtbW5iS2VCb2tVdUVwMHJR?oc=5","date":"2026-03-31","type":"deal","source":"BioSpace","summary":"Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation - BioSpace","headline":"Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPdU10a3JqWDBiNjlzOW9MemJPNko1NzZaMEplVkxfZXRVS2plaTljNGJ5RUlybmpJaTRFMVVVVGxsRmRiTDVURGpZczZrVnBaV25BV2ZPbnJ0akNVa2V4MVJSSGx4a1RmcDV4TzN5VkhOR3ppMWpXckpUWEpOejRscWdyNDJOOHdCRG93aTZDeU8?oc=5","date":"2026-03-11","type":"trial","source":"Market Data Forecast","summary":"Induced Pluripotent Stem Cells Market Size Report, 2034 - Market Data Forecast","headline":"Induced Pluripotent Stem Cells Market Size Report, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNTFVNaHJFVkVJUlFwb29Td3kzakRWaVlRdU9fZjk5WGoxb3BMLVNCeFpiUk8xS3h3Q1psZVQyMk53eFk3SzFyVWQ0YjBRa2JsNXhPRzd5dGhMazRPOUE1Q1NEUGVGUmN1ZElBQms5U1E3VHlfSHJMcVZjcDhyNW5Nd09XaW4xejRzU21RYVdVNTMycDJpcG16b2NZTXZsUVdBYkU1SjdjZ3RpejNHbkFscmdvZXZvUTJWT0xYSG53d1hnZ3RScEh2dTA4bUxxVU1FUUNqX181REdsbHlZc2lRTmcxakx2Ym8?oc=5","date":"2026-02-26","type":"pipeline","source":"BioSpace","summary":"Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026 - BioSpace","headline":"Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOUDBRR0ZuUUhGcXR3MVZaMDBtRTlnUWxXbzRaRVFJSzlCYTlaNE1udTIwVFl1WnR1MXk5U2VldlllMXRlUV95eTZNTmx3b3hWemhkT1JvQS1hRElvN1RoX2lRc015RENiMnIzd3RLOUFyTTZoYzhPV21JYVJ2cFJYSHhpeW5CNmhNUGFmTDh2OFRZY0E?oc=5","date":"2025-11-27","type":"pipeline","source":"Grand View Research","summary":"Stem Cell Culture Media Market Size | Industry Report, 2033 - Grand View Research","headline":"Stem Cell Culture Media Market Size | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQbzZyZWFLSWdkSFlROGJYenJYY013SlF6Q1N0bjBiMndNY1Jab3RKYVp6SnRycnJOY0hYb0lSaXFrQ1ZsN1lWclFDNVExNVN0Z1pXbWItSEhxVk1kRHIzMlFoV3V3RlJjeEZDWE03b3Y1NXZHQ01kLUVNUGJMV0h1QmJld3lmc3RCZGJOSTVnR0lYOGVrQTMzXzhVT3kzdEtLVmJMNVd1RUZWMERmUEt3UFBQZ3AtYm1neDBrbktoNG02bk5QTnEwazUxR3ZpdVhDWURZN3B5M3RmdjFILUYyQ3FBOVNiV2E0VTM5dXJJQ1JvYlBIS0dWOGRNN28yUVNZbXlVTnVQaVNSdVhibjJPeXhpNHFHVkY4cWRndWJnRmpoNmY2QnY2bQ?oc=5","date":"2025-10-09","type":"pipeline","source":"News-Medical","summary":"Takara Bio USA, Inc. announces a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology - News-Medical","headline":"Takara Bio USA, Inc. announces a series of updates to its spatial biology product portfolio, extending its innovation wi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE5EUDhSY0JoZmtwVWFxaXFSaW13ekk1QTA2bEFnY2NfUGh5V0h2MlE1em44bDdNQXRCUEdsQ3lydVMzUW1tLVFVdnVFZTNDNUh0dGJfZExqRzQtWWhCUjgyS0x2V2I?oc=5","date":"2025-03-11","type":"regulatory","source":"Straits Research","summary":"Glycobiology Market Size, Global Trends, Demand, Report By 2033 - Straits Research","headline":"Glycobiology Market Size, Global Trends, Demand, Report By 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOQ1BqejQtbXNLaTlvY1VPUHZLb2Vadm4weDNhOWFSeC1NWDFQRmo3M0dlU05ZSHZBVnVaVGJfaWE1d0EzNklHX1U5UUM2R3R3c3pkbjVINEctdkRrWWg5R19fNzlob0ZUYUQwbzRXSFpJa1NtQjdZY0ZQTTNvSTZVM3NMbzhtTTRkTml5SjNHUGhMa1NzVk9PMk1QQVc?oc=5","date":"2025-03-06","type":"pipeline","source":"Drug Discovery News","summary":"Joining forces to advance single-cell spatial multiomics - Drug Discovery News","headline":"Joining forces to advance single-cell spatial multiomics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxObGJkcHZlejdoYWZUaDZiR1FFWjA0MU1fa3d0MGNYRlZvTXptaWlQYnZqZTR4SW9VeTBfWjNWcm1nOS1VS010NW9HdGNudERUdEE5S0NWWWZWdW5zb3FBSHpfbk9MTGVkVlJHbnIwbTZuaTU3UXplNHBiMHNBaEdPMnhuRjl5eUs1Z3lwX3gxTDF2Tzd4RDk4OGxoOVIxSXd2Q0VCelhUNm1OdF9qeGNHbDVVQ1pObjJaYkdHWXp1M1R3dU1IM0hNMUhCYXpXMjQ3c0pvYmZ1S3lSVjh6LXJtS0p3?oc=5","date":"2024-05-30","type":"pipeline","source":"BioPharma APAC","summary":"Takara Bio Inc. Launches Large-Scale Viral Vector Manufacturing with Thermo Fisher’s DynaDrive Bioreactors - BioPharma APAC","headline":"Takara Bio Inc. Launches Large-Scale Viral Vector Manufacturing with Thermo Fisher’s DynaDrive Bioreactors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNTmtpYURaVEhPYkNqc0FkczdWaHNyQXpkVXRSaVRUT0RDTm42bDQ1N1d3eDh6ZXd6czdkVGdPak5IbGxaekROMEduQnJ2LUdzMFJpbTNyVlRuVDBQMmxHbFZFTlBOS3JvbkgwMVYxSEJnenNnU0dvaF9yUDMtTmxjcXVMeWRxX1hMZ3hTcXdVdFpGM0tUYjFmdHIxbDh4OE5iTVlBQ3Q4V2JyY0g1cWpnZmdzV21yMktObTJNMmY3X2FBQ2R0aXBKbEtOOElkdS1iSnd3SGNRWHNlYzdVT3VBTkh4cklVU0dsaWF2dlhmUnZKNmRBLUplLVhpSm8tODJnNVdHVWlxQUR3U1ZIRVFxYVdPczVMSXhxOGc?oc=5","date":"2023-05-10","type":"pipeline","source":"PR Newswire","summary":"Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight - PR Newswire","headline":"Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5wc2YzaVUzN1BoaFhNdUJrd1FkVktyZ1hjOVFwYzNUTkZRTkIyTUhUMEdxZVZCeEw5aUpBUjN4UEE1dG53V1pEMjd6VkNXeEFaaFRrTg?oc=5","date":"2020-11-07","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Takara Bio Inc. (4974.T) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Takara Bio Inc. (4974.T) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQQVY2TzEzUWhzS3FiS2dhdnoyUEhJZEJZaWJBbzA2bFpPeGJKNzRLb2RZcV81cnktelcxZTdUcGdKZENsTG5yUWJHMTlDSFFTNXpzZzdQUXRpUVpEbWNyY3cyeVhQUnhUdk5oYUhrWTZoVnJ4Q3FCRlRVQV9XSHZGMnd4ZW5KYWdZdHBGOTc4dTlCTXRqVFJ4Yk5sa3Jka2JRWkVuSU1PLW5WaW9xQTdKLV8yT0VqdkE?oc=5","date":"2020-05-29","type":"pipeline","source":"Pharmaceutical Technology","summary":"Takara Bio’s Center for Gene and Cell Therapy Processing II, Shiga, Japan - Pharmaceutical Technology","headline":"Takara Bio’s Center for Gene and Cell Therapy Processing II, Shiga, Japan","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_3":1,"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}